Millennium Management’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-118,240
| Closed | -$1.79M | – | 7652 |
|
|
2022
Q3 | $1.79M | Buy |
118,240
+75,360
| +176% | +$876K | ﹤0.01% | 3851 |
|
|
2022
Q2 | $322K | Sell |
42,880
-589,297
| -93% | -$4.15M | ﹤0.01% | 5306 |
|
|
2022
Q1 | $5.75M | Sell |
632,177
-385,488
| -38% | -$2.97M | ﹤0.01% | 2783 |
|
|
2021
Q4 | $7.14M | Buy |
1,017,665
+889,851
| +696% | +$9.31M | ﹤0.01% | 2529 |
|
|
2021
Q3 | $1.46M | Sell |
127,814
-78,784
| -38% | -$1.15M | ﹤0.01% | 4271 |
|
|
2021
Q2 | $3.31M | Buy |
206,598
+131,748
| +176% | +$2.26M | ﹤0.01% | 3322 |
|
|
2021
Q1 | $1.34M | Sell |
74,850
-82,965
| -53% | -$1.43M | ﹤0.01% | 3911 |
|
|
2020
Q4 | $2.13M | Buy |
157,815
+131,591
| +502% | +$1.59M | ﹤0.01% | 3190 |
|
|
2020
Q3 | $309 | Sell |
26,224
-169,546
| -87% | -$2.07M | ﹤0.01% | 3831 |
|
|
2020
Q2 | $2.89M | Buy |
+195,770
| New | +$2.9M | ﹤0.01% | 2250 |
|
|
2019
Q4 | – | Sell |
-132,183
| Closed | -$2.54M | – | 4766 |
|
|
2019
Q3 | $2.54M | Sell |
132,183
-184,045
| -58% | -$4.22M | ﹤0.01% | 2298 |
|
|
2019
Q2 | $9.35M | Sell |
316,228
-178,714
| -36% | -$6.89M | 0.01% | 1315 |
|
|
2019
Q1 | $23.5M | Buy |
494,942
+272,042
| +122% | +$12M | 0.04% | 712 |
|
|
2018
Q4 | $8.05M | Sell |
222,900
-135,055
| -38% | -$6.34M | 0.01% | 1261 |
|
|
2018
Q3 | $22M | Buy |
357,955
+98,576
| +38% | +$6.34M | 0.03% | 803 |
|
|
2018
Q2 | $17.5M | Sell |
259,379
-129,012
| -33% | -$7.22M | 0.02% | 935 |
|
|
2018
Q1 | $21.1M | Buy |
388,391
+13,736
| +4% | +$768K | 0.03% | 845 |
|
|
2017
Q4 | $22.4M | Buy |
374,655
+109,857
| +41% | +$6.66M | 0.03% | 837 |
|
|
2017
Q3 | $12.9M | Sell |
264,798
-208,658
| -44% | -$11.4M | 0.02% | 1083 |
|
|
2017
Q2 | $24.9M | Sell |
473,456
-613,089
| -56% | -$28.5M | 0.04% | 576 |
|
|
2017
Q1 | $49.3M | Buy |
1,086,545
+210,643
| +24% | +$9.39M | 0.09% | 312 |
|
|
2016
Q4 | $33.2M | Buy |
875,902
+654,444
| +296% | +$24.7M | 0.07% | 398 |
|
|
2016
Q3 | $8.36M | Buy |
+221,458
| New | +$4.88M | 0.01% | 1032 |
|
|
2016
Q1 | – | Sell |
-584,877
| Closed | -$14.2M | – | 3778 |
|
|
2015
Q4 | $14.2M | Sell |
584,877
-720,676
| -55% | -$16.8M | 0.03% | 723 |
|
|
2015
Q3 | $23.2M | Buy |
1,305,553
+1,021,302
| +359% | +$18.5M | 0.04% | 503 |
|
|
2015
Q2 | $5.02M | Sell |
284,251
-275,090
| -49% | -$5.04M | 0.01% | 1394 |
|
|
2015
Q1 | $17.5M | Buy |
559,341
+422,949
| +310% | +$12.3M | 0.03% | 729 |
|
|
2014
Q4 | $3.98M | Buy |
136,392
+57,024
| +72% | +$1.45M | 0.01% | 1544 |
|
|
2014
Q3 | $1.64M | Buy |
79,368
+43,165
| +119% | +$851K | ﹤0.01% | 2001 |
|
|
2014
Q2 | $897K | Buy |
+36,203
| New | +$627K | ﹤0.01% | 2260 |
|
|
2014
Q1 | – | Sell |
-106,940
| Closed | -$1.92M | – | 3994 |
|
|
2013
Q4 | $1.92M | Buy |
+106,940
| New | +$1.39M | 0.01% | 1855 |
|
Millennium Management's AERI Position: Q4 2022 in Review
Millennium Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 118,240 shares — an estimated $1.79M sold.
Millennium Management first reported a position in AERI in Q4 2013 and held it in 31 quarters. The position peaked at $49.3M in Q1 2017. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Millennium Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Millennium Management sold 118,240 Aerie Pharmaceuticals shares in Q4 2022, an estimated $1.79M.
- Millennium Management first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 31 quarters.
- Millennium Management's Aerie Pharmaceuticals position peaked at $49.3M in Q1 2017.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.